Insurance coverage would expand access for the expensive treatments. The post Medical Insurance Providers Assess Benefits of Psychedelics Treatments appeared...
The article Numinus Wellness Reports Q4 2022 and Annual Results was originally published on Microdose. Numinus Wellness Reports Q4 2022 and Annual Results...
The article Field Trip Announces New Ketamine Therapy Program: Freedom by Field Trip™ was originally published on Microdose. Field Trip Announces the...
Despite a challenging economy, psychedelics companies have accelerated development. The post Recession Predictions Not Slowing Psychedelics Industry appeared...
The article Numinus Launches Ketamine Program for Chronic and Serious Illness was originally published on Microdose. Numinus Launches Psychedelic-Assisted...
Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce...
Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in...
Mydecine Innovations Group Inc. (NEO: MYCO | OTC: MYCOF | FSE: 0NFA) a biotechnology company engineering the next wave of innovative medications and treatment...
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada The post Field Trip facilitates beneficial...
The Daily Hit is a recap of the top cannabis business stories for May 12, 2022. ON THE SITE Trulieve Cannabis Corp. on Track to do...